drugset / Trial / NCT04616235

Acute Exercise and NK Cell Regulation in Tissue and Circulation After IL-6R Blockade

NCT04616235

Completed 30 enrolled Rigshospitalet, Denmark
RandomizedParallel-groupTriple-blindBasic science

Summary

The study is a randomized controlled trial studying the acute effect of intense aerobic exercise upon NK (Natural Killer) cell activation and appetite-regulation in human participants with or without concommitant IL-6R receptor blockade (Tocilizumab)

Timeline

Start
2021-03-15
Primary completion
2021-10-04
Completion
2021-10-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tocilizumab Monoclonal antibody Intravenous

Indications

No indication recorded.